Ichosia Biotechnology

About Us

Ichosia Biotechnology is developing a scalable method of mass producing an enhanced red blood cell product, Erythrosyn, created with novel genetic engineering and stem cell techniques. With this technology, Ichosia is solved the global blood crisis by making blood safer, less expensive, and more reliable.

United States


Contact: Lucas Vining

Email: lucas.vining@ichosia.com

Stage: Build

Profit / Non Profit: For Profit